Visit our FacebookVisit our InstagramVisit our Twitter

Cambium Bio Successfully Closes A$3.0M Financing Round

2024-12-05T03:58:03Z

SYDNEY, Dec. 05, 2024 (GLOBE NEWSWIRE) --  Cambium Bio Limited (ASX:CMB) (Cambium Bio, Cambium or Company), a clinical-stage regenerative medicine company focusing on the development of innovative biologics for ophthalmology and tissue repair applications, is pleased to announce the successful completion of a A$3.0 million capital raising.

Key Highlights:

  • Capital raising of A$3.0 million completed at A$0.4637 per share, representing a 25% discount to the 5-day Volume Weighted Average Price (VWAP) up to and including 2 December 2024
  • Strong support from new strategic investor AventaCell Biomedical Corp and existing major shareholder Zheng Yang Biomedical Technology
  • Additional participation from Cambium Bio directors, CEO, and Australian institutional and sophisticated investors
  • Proceeds to advance Phase 3 clinical development of Elate Ocular® for dry eye disease

The capital raising, which was approved by shareholders at the Annual General Meeting held on 26 November 2024, comprises:

  • A$1.5 million strategic investment from AventaCell Biomedical Corp
  • A$0.25 million investment from Zheng Yang Biomedical Technology
  • A$0.146 million from Cambium Bio directors
  • A$1.054 million from Cambium Bio CEO, Australian institutional, sophisticated and other investors

Cambium Bio CEO, Karolis Rosickas, commented: "We are delighted with the strong support received in this capital raising, particularly from AventaCell Biomedical Corp as a new strategic investor. AventaCell's global leadership in cell culture supplements using our human platelet technology makes them an ideal partner as we advance our therapeutic programs. The participation of our existing major shareholder ZYBT, along with directors and management, demonstrates continued confidence in our strategy and clinical and commercial potential of Elate Ocular®."

Use of Funds

The proceeds will primarily support the advancement of Elate Ocular® through its registration-enabling Phase 3 clinical trials for dry eye disease, which are planned to commence in calendar Q2 2025. The funds will also provide working capital for the Company's ongoing operations.

For further information, please contact:
Helen Leung
Corporate Secretary
info@cambium.bio
1 300 995 098


Globe Newswire News

RSS Australian Mining Releases

  • Confidence Boosting Infill Drilling at Nyanzaga Project
    Perth, Dec. 05, 2024 (GLOBE NEWSWIRE) -- CONFIDENCE BOOSTING INFILL DRILLING AT NYANZAGA PROJECT Perth, Western Australia/December 5, 2024/ Perseus Mining Limited (ASX/TSX: PRU) is pleased to provide an update on ongoing resource definition drilling being conducted at its recently acquired Nyanzaga Gold Project in Tanzania (Nyanzaga or the Project). Designed to increase Perseus’s understanding […]
  • Perseus Mining General Meeting Results
    Perth, Nov. 25, 2024 (GLOBE NEWSWIRE) -- ANNUAL GENERAL MEETING RESULTS Perseus Mining Limited (ASX/TSX: PRU) (Perseus) wishes to release the results of its Annual General Meeting, held on 22 November 2024 at 3pm AWST. All six resolutions were decided on a poll and passed. In accordance with ASX Listing Rule 3.13.2 and Section 251AA […]
  • High Priority Copper Drill Targets Defined at Sant Tolgoi
    TORONTO, Nov. 20, 2024 (GLOBE NEWSWIRE) -- Xanadu Mines Ltd (ASX: XAM, TSX: XAM) (Xanadu or the Company) is pleased to announce strong surface copper assay results from its Sant Tolgoi Project located in Zavkhan Province of Western Mongolia (Figures 1 and 2). Geological mapping, surface rock-chip sampling and geophysics have confirmed the preference of […]
  • Funding Expanded to $7.5 million & Section 708A(5)(e) Notice
    Not for release to US wire services or distribution in the United States Highlights 4 November Placement expanded to $7.5 million, an increase of $2.0 million on the same termsIncludes 10 million new shares to a sophisticated Australian investorIncludes 26.5 million new shares to Zijin Mining Group Co., Ltd (Zijin) for $1.46 million to maintain […]
  • Xanadu Mines Completes $5.5 Million Placement
    Not for release to US wire services or distribution in the United States TORONTO, Nov. 11, 2024 (GLOBE NEWSWIRE) -- Xanadu Mines Ltd (ASX:XAM, TSX:XAM) (Xanadu or the Company) advises that on 8 November 2024, it issued 100,000,004 fully paid ordinary shares at a price of $0.055 per share, to a range of sophisticated investors […]
  • Xanadu Mines Announces $5.5 Million Placement
    Not for release to US wire services or distribution in the United States Highlights Firm commitments received for a Placement to raise approximately $5.5 million (before costs).The Placement was well supported by both domestic and international, natural resources-focused institutional investors.The Placement may be expanded to include other potential strategic parties on similar terms, subject to […]
  • Perseus Mining September Quarter Report
    Perth, Oct. 23, 2024 (GLOBE NEWSWIRE) -- Perseus Mining consistently delivers strong production, cashflow and growth, resulting in a cash & bullion balance of US$643 million Perseus Mining Limited (“Perseus” or the “Company”) (TSX & ASX: PRU) reports on its activities for the three months’ period ended September 30, 2024 (the “Quarter”). Key operating indicators […]
  • Kharmagtai Maiden Ore Reserve, Updated Mineral Resource
    TORONTO, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Xanadu Mines Ltd (ASX: XAM, TSX: XAM) (Xanadu, XAM or the Company) is pleased to report an increase in the Mineral Resource Estimate (Resource, Mineral Resource Estimate or MRE) and a Maiden Ore Reserve for its flagship copper-gold project at Kharmagtai, in the South Gobi region of Mongolia […]
  • Pre-Feasibility Study – Kharmagtai Copper-Gold Project
    TORONTO, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Xanadu Mines Ltd (ASX:XAM, TSX:XAM) (Xanadu, XAM or the Company) is pleased to provide the Pre-Feasibility Study (PFS) for its flagship Kharmagtai Copper-Gold Project (Kharmagtai or the Project), located in an established mining jurisdiction in the South Gobi region of Mongolia. This Study confirms the potential of Kharmagtai […]
  • Perseus Mining September Quarter Investor Webinar
    Perth, Oct. 07, 2024 (GLOBE NEWSWIRE) -- QUARTERLY REPORT INVESTOR WEBINAR / CALL Perth, Western Australia/October 7, 2024/ Perseus Mining Limited (ASX/TSX: PRU) is hosting an investor webinar and conference call to discuss its September 2024 Quarterly Results, which are anticipated for release around 8:30am AEDT on Wednesday 23 October 2024. CALL DETAILS Australia: Wednesday […]

Stay up to date

Get notified about the latest gold mining news as soon as it happens or choose daily or weekly deliveries.
GET Newsletters
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram